These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2407166)

  • 41. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test.
    Saito H; Soma Y; Nakajima M; Koeda J; Kawaguchi H; Kakizaki R; Chiba R; Aisawa T; Munakata A
    Oncol Rep; 2000; 7(4):815-9. PubMed ID: 10854550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimated mean sojourn time associated with hemoccult SENSA for detection of proximal and distal colorectal cancer.
    Zheng W; Rutter CM
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1722-30. PubMed ID: 22911331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for colorectal cancer by immunochemical fecal occult blood testing.
    Saito H
    Jpn J Cancer Res; 1996 Oct; 87(10):1011-24. PubMed ID: 8957057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
    Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
    Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Colonic CT-imaging or virtual coloscopy].
    Pilleul F
    Rev Med Suisse; 2010 Mar; 6(240):584-7. PubMed ID: 20408464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
    Reilly JM; Ballantyne GH; Fleming FX; Zucker KA; Modlin IM
    Am Surg; 1990 Mar; 56(3):119-23. PubMed ID: 2316930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moisture content of Hemoccult slides influences test sensitivity.
    Faure H; Exbrayat C; Winckel P; Bolla M
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1111-4. PubMed ID: 14501620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Informative value of Hemoccult test according to the number of positive slides in mass screening of colorectal cancer].
    Tazi MA; Faivre J; Lejeune C; Dassonville F; Benhamiche AM
    Bull Cancer; 1998 Dec; 85(12):1055-9. PubMed ID: 9917557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler B; Irwig L; Glasziou P; Kewenter J; Weller D; Silagy C
    BMJ; 1998 Aug; 317(7158):559-65. PubMed ID: 9721111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The diagnostic value of the hemoccult as a screening test in patients taking anticoagulants.
    Kewenter J; Svanvik J; Svensson C; Wållgren K
    Cancer; 1984 Dec; 54(12):3054-8. PubMed ID: 6498780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
    Blom J; Törnberg S
    J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
    Macrae FA; St John DJ
    Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved screening for colorectal cancer by immunological detection of occult blood.
    Frommer DJ; Kapparis A; Brown MK
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1092-4. PubMed ID: 3132220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of the 'directions for use' on positivity rates of the Hemoccult II test.
    Faure H; Exbrayat C; Garnier A; Dumas P; Winckel P; Bolla M
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1021-4. PubMed ID: 9895048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.